Building laboratory capacity for HIV, hepatitis and STIs
Overview
Indonesia is home to over 124 million people in need of preventive chemotherapy (PCT) treatment. This situation reflected the burden of Neglected Tropical Disease in Indonesia than in other countries in South-East Asia Region. In 2017, 50.7 million people were targeted with PCT medicine for LF and 39.7 million people (78.2%) were covered. The country has also protected approximately 12.3 million pre-School Age Children and 20.7 million school age children with PCT medicine for Soil Transmitted Helminthiasis in 2017. Indonesia is the only country in the SEA Region that requires preventive chemotherapy for schistosomiasis, with the disease located in one province (Central Sulawesi).
WHO is mandated to facilitate the donation of Preventive Chemotherapy (PCT) medicines which is an inspiring programme to make changes. It has also reflected the power of partnerships to address huge-scale public health intervention. In the context of Indonesia, GlaxoSmithkline, EISAI, and MERCK have committed to provide massive or even unlimited supply of medicines against vector-borne NTDs while Novartis pledged to provide MDT medicine for leprosy until the diseases are either controlled or eliminated. Since 2006, WHO has provided 326,700,000 tablets of DEC and 392,789,000 Albendazole tablets for Lymphatic Filariasis Elimination programme, 480,000 tablets of praziquantel for schistosomiasis programme, and 303,847 blisters of Multi-Drugs-Therapy (MDT) medicine for leprosy (only for 2018 treatment) for the elimination of NTDs in Indonesia.